Amanote Research
Register
Sign In
Orphan Designation: (S)-(−)-3-(4-Aminophenyl)-2-Methoxypropanoic Acid, Treatment of Idiopathic Pulmonary Fibrosis
Case Medical Research
doi 10.31525/cmr-6ac700
Full Text
Open PDF
Abstract
Available in
full text
Date
December 19, 2018
Authors
Unknown
Publisher
Case Journals
Related search
Orphan Designation: 3-Pentylbenzeneacetic Acid Sodium Salt, Treatment of Alström Syndrome
Case Medical Research
Orphan Designation: (2r,3s)-2-(4-Cyclopentylaminophenyl)-1-(2-Fluoro-6-Methylbenzoyl)piperidine-3-Carboxylic Acid(4-Methyl-3-Trifluoromethylphenyl)amNide, Treatment of Microscopic Polyangiitis (Avacopan)
Case Medical Research
Orphan Designation: 4-Hydroxy-6-{2-[4-(Trifluoromethyl)phenyl]ethyl}pyridazin-3(2h)-One, Treatment of Friedreich’s Ataxia
Case Medical Research
Orphan Designation: (2r,3s)-2-(4-Cyclopentylaminophenyl)-1-(2-Fluoro-6-Methylbenzoyl)piperidine-3-Carboxylic Acid(4-Methyl-3-Trifluoromethylphenyl)amide (Avacopan), Treatment of Granulomatosis With Polyangiitis
Case Medical Research
Orphan Designation: Glyceryl Tri-(4-Phenylbutyrate), Treatment of Argininosuccinic Aciduria
Case Medical Research
Orphan Designation: Brincidofovir, Treatment of Smallpox
Case Medical Research
Orphan Designation: Codon-Optimised Human Cystic Fibrosis Transmembrane Conductance Regulator Messenger Ribonucleic Acid Complexed With Lipid-Based Nanoparticles, Treatment of Cystic Fibrosis
Case Medical Research
Orphan Designation: Pomalidomide, Treatment of Multiple Myeloma
Case Medical Research
Idiopathic Pulmonary Fibrosis
Pulmonologiya
Pulmonary
Respiratory Medicine
